Healthcare providers should counsel patients on three critical findings about magnesium supplementation based on current evidence. First, animal studies showing tissue-specific accumulation of different magnesium salts have not reliably translated to human outcomes, making marketing claims about brain-targeted or anxiety-reducing forms largely unsubstantiated. Second, clinical trials demonstrate that multiple magnesium forms—oxide, citrate, glycinate, and others—produce similar cognitive and sleep benefits when properly dosed.
Third and most importantly, individual factors like baseline magnesium deficiency and total daily dose are stronger predictors of supplement success than the specific salt type chosen. These insights help clinicians provide evidence-based recommendations rather than reinforcing marketing narratives. Patients benefit from understanding that generic, cost-effective magnesium formulations may work as effectively as premium, specialized variants marketed at higher prices.
Read the full article on GMJ Newsroom.
Was this article helpful?
